/

Società

Am

Non verificato

AmacaThera Inc.

Di cosa scriviamo

BiologiaEconomiaFarmaceuticaSanitàStart-up

3 comunicati stampa

Guarda tutti i comunicati

08/04/2025

Farmaceutica

Sanità

Biologia

Amacathera Collaborates With Leading Global Pharmaceutical Company To Develop Single-Injection, Long-Acting Biologic Using Its Advanced Hydrogel Delivery Platform, Amacagel(TM)

Fonte

AmacaThera Inc.

Emittente

1.00

0

Press Release cover image

08/01/2025

Farmaceutica

Sanità

Economia

Management

Organizzazione Aziendale

Biologia

Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies

Fonte

AmacaThera Inc.

Emittente

1.00

0

Press Release cover image

20/11/2024

Farmaceutica

Sanità

AmacaThera Announces Phase 1 Results of First-in-Human Study with AMT-143, Exceeding Expectations and Paving the Way for a Novel Approach to Post-Operative Pain Relief

Fonte

AmacaThera Inc.

Emittente

1.00

0

Seguaci

0

Compatibilità

0